racemetirosine has been researched along with Cancer of Mouth in 2 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, M | 2 |
| Higuchi, T | 2 |
| Nakajima, T | 1 |
| Andriana, P | 1 |
| Hirasawa, H | 1 |
| Tokue, A | 1 |
| Kurihara, J | 1 |
| Yokoo, S | 2 |
| Tsushima, Y | 2 |
| Achmad, A | 1 |
| Arisaka, Y | 1 |
| Yokoo, H | 1 |
2 other studies available for racemetirosine and Cancer of Mouth
| Article | Year |
|---|---|
Topics: alpha-Methyltyrosine; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Pos | 2019 |
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Female; Fluorodeoxyg | 2015 |